Application of in situ hybridization with a novel phenytoin-labeled probe to conventional formalin-fixed, paraffin-embedded tissue sections. 1995

Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
Department of Microbiology, Miyazaki Medical College, Japan.

Non-isotopic in situ hybridization with a novel phenytoin (PHE)-labeled probe was developed. The mixture of cloned cytomegalovirus (CMV) DNA fragments was labeled by random primer technique using PHE-11(spacer)-dUTP, instead of dTTP. The tissue sections were treated with 0.2 N HCl and with proteinase K (1 microgram/ml), and then heated at 70 degrees C in the presence of 50 or 75% formamide. The sections were hybridized with PHE-labeled probe at 37 degrees C overnight. The hybridization signal was visualized by alkaline phosphatase-5-bromo-4-chloro-3-indolyl phosphate (BCIP)/4-nitroblue tetazolium (NBT) system. Strong hybridization signals were detected in sections of the small intestine and the placenta, even when denatured in the presence of 50% formamide. In the case of small intestine, CMV DNA was also detected in the endothelial cells of the mucosa where apparent infected cell was not observed histologically. In the sections of the submaxillary gland, the lung, the adrenal gland and the ovary, hybridization signal was not detected when denatured in the presence of 50% formamide, but detected after denaturation with 75% formamide. Thus, in situ hybridization with the novel PHE-labeled probe is applicable to conventional formalin-fixed, paraffin-embedded tissue sections.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D005260 Female Females
D005557 Formaldehyde A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) Formalin,Formol,Methanal,Oxomethane

Related Publications

Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
January 2011, Methods in molecular biology (Clifton, N.J.),
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
April 1999, Brain research. Brain research protocols,
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
February 1987, Journal of virological methods,
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
August 2002, Rinsho byori. The Japanese journal of clinical pathology,
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
October 1993, The Journal of pathology,
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
January 1993, Avian diseases,
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
January 2010, Methods in molecular biology (Clifton, N.J.),
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
September 2004, Expert review of molecular diagnostics,
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
January 2018, Oncology letters,
Y Eizuru, and Y Minamishima, and T Matsumoto, and T Hamakado, and M Mizukoshi, and K Nabeshima, and M Koono, and A Yoshida, and H Yoshida, and M Kikuchi
December 2009, American journal of clinical pathology,
Copied contents to your clipboard!